Media OutReach Newswire – 5 February 2025 – AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, announced today that its independently developed ...

Investigators from the Food and Drug Administration are working on a new Salmonella outbreak of unknown origin. The ...

Recently, the Government Accountability Office issued a report calling for a unified food safety strategy. There aren’t too ...

First-of-its-kind treatment to be approved by FDA in more than a decade, Pradalex is now available to treat swine and bovine respiratory diseases.

The company eliminated the dye back in 2013 and already offered 10 dye-free versions of its flavors. Recently, they added ...

Its cash, cash equivalents, and short-term marketable securities balance was around $1.2 billion in 2022, and we expect the trend of no/low debt and deep pockets of cash to continue over the next five ...

The U.S. Food and Drug Administration upgraded the classification of recalled broccoli sold at Walmart originally issued in ...

The snacks are now part of a Class I recall, which is for products with the potential of "serious adverse health consequences ...

In some of her strongest language to date, U.S. Sen. Jeanne Shaheen said President Donald Trump's actions on spending, tariffs and shutting down foreign assistance programs appear to be a "deliberate ...

WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Symbravo (meloxicam and ...

Susvimo is the first and only FDA-approved treatment shown to maintain vision in people with diabetic macular edema with ...

Cerebral cavernous malformation (CCM) patients treated with oral drug, REC-994, showed reduction in total cerebral and brainstem lesion volume.